Dive into the fascinating world of immunoglobulin A nephropathy (IgAN), the most common form of primary glomerulonephritis worldwide.

Credit available for this activity expires: 7/16/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001351?ecd=bdc_podcast_libsyn_mscpedu

Are you providing culturally competent care for your Hispanic patients?

Credit available for this activity expires: 7/12/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001327?ecd=bdc_podcast_libsyn_mscpedu

Did you know 59% of patients value doctors asking about their information needs and desired level of care involvement? Join us to explore these and other insights in relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL).

Credit available for this activity expires: 7/5/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001303?ecd=bdc_podcast_libsyn_mscpedu

Are you aware of the DREAM protocol that can facilitate a 2-way exchange between patients and clinicians? Credit available for this activity expires: 6/28/2025 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001200?ecd=bdc_podcast_libsyn_mscpedu

Short on time? You can still screen for these function-limiting symptoms.

Credit available for this activity expires: 6/26/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001208?ecd=bdc_podcast_libsyn_mscpedu

Did you know that targeting the OX40-OX40 ligand (OX40-OX40L) pathway may lead to long-term remission in atopic dermatitis (AD)?

Credit available for this activity expires: 6/26/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001214?ecd=bdc_podcast_libsyn_mscpedu

How would you manage a patient with metabolic syndrome and metabolic dysfunction-associated steatohepatitis?

Credit available for this activity expires: 6/26/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001260?ecd=bdc_podcast_libsyn_mscpedu

Get the latest data from ASCO 2024 about anti-HER2 therapies in biliary tract cancer.

Credit available for this activity expires: 6/25/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001250?ecd=bdc_podcast_libsyn_mscpedu

Are you aware of patients' perceptions and wishes about diagnosis and management of transthyretin amyloid cardiomyopathy (ATTR-CM)?

Credit available for this activity expires: 6/18/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001176?ecd=bdc_podcast_libsyn_mscpedu

How much do you know about new acid suppressive treatments for gastroesophageal reflux disease (GERD)?

Credit available for this activity expires: 6/12/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001195?ecd=bdc_podcast_libsyn_mscpedu